{"name":"α-Ethyltryptamine","slug":"α-ethyltryptamine","kind":"substance","abbreviations":["αET"],"systematic":null,"aliases":["Etryptamine","3-(2-Aminobutyl)indole","Etriptamina","3-Indolylbutylamine","Etryptaminum","Monase","Ro 3-1932","1H-Indole-3-ethanamine, α-ethyl-","2-ethyltryptamine","3-(2-aminobutylindole)"],"brands":[],"scraped":true,"has_structure":true,"cid":8367,"classes":[{"name":"entactogen","href":"/class/entactogen"},{"name":"stimulant","href":"/class/stimulant"}],"families":[{"name":"α-alkyltryptamine","href":"/substituted/%CE%B1-alkyltryptamine"}],"physical":[{"label":"Molecular mass","value":"188.27 g/mol","copyable":false},{"label":"Melting point","value":"221","copyable":false},{"label":"Solubility","value":"510 mg/L","copyable":false},{"label":"Predicted LogP","value":"2.5","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"1-(1H-indol-3-yl)butan-2-amine","copyable":true},{"label":"SMILES","value":"CCC(CC1=CNC2=CC=CC=C21)N","copyable":true},{"label":"InChI","value":"InChI=1S/C12H16N2/c1-2-10(13)7-9-8-14-12-6-4-3-5-11(9)12/h3-6,8,10,14H,2,7,13H2,1H3","copyable":true},{"label":"InChIKey","value":"ZXUMUPVQYAFTLF-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"2235-90-7","copyable":true},{"label":"UNII","value":"GR181O3R32","copyable":true},{"label":"PubChem CID","value":"8367","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"0.5–1.5 hours","copyable":false},{"label":"Elimination half-life","value":"~8 hours","copyable":false},{"label":"Duration of action","value":"6–8 hours (100–150 mg)","copyable":false},{"label":"Metabolism","value":"Hydroxylation","copyable":false},{"label":"Excretion","value":"Urine (majority)","copyable":false},{"label":"Routes of administration","value":"Oral","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"α-Ethyltryptamine hydrochloride","name":"hydrochloride","slug":"α-ethyltryptamine_hydrochloride","drawn":true},{"title":"α-Ethyltryptamine acetate","name":"acetate","slug":"α-ethyltryptamine_acetate","drawn":true}],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[{"name":"Etryptamine, (R)-","href":"/substance/etryptamine,_%28r%29-"},{"name":"(S)-α-Ethyltryptamine","href":"/substance/%28s%29-%CE%B1-ethyltryptamine"}],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"MAOB","mechanisms":["shared target"],"partners":3,"contraindicated":3}],"mechanism":"The mechanism of action responsible for its antidepressant activity  was believed to lie in its ability to inhibit monoamine oxidase, while its stimulant activity on the central nervous system appeared to result from its structural similarity to indole-based psychedelics. [5]    Research discovered αET to be both a monoamine oxidase inhibitor and a potent monoamine releasing agent capable of serotonergic neurotoxicity. [3]  The ability to release serotonin was linked to αET's MDMA like properties. [2] αET has been shown to release serotonin pre-synaptically, as well as lesser amounts of norepinephrine and dopamine.","side_effects":null,"effects":{"groups":[["Physical Effects",["Abnormal heartbeat","Appetite suppression","Dehydration","Dry mouth","Increased blood pressure","Increased heart rate","Increased libido","Restless legs","Shakiness","Stamina enhancement","Stimulation","Teeth grinding","Vasoconstriction"]],["Cognitive Effects",["Analysis enhancement","Cognitive euphoria","Compulsive redosing","Disinhibition","Ego inflation","Empathy, affection, and sociability enhancement","Focus enhancement","Increased music appreciation","Mania","Motivation enhancement","Suggestibility suppression","Thought acceleration","Wakefulness"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"F2","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule III","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule I","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"United Kingdom","status":"Class A","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"Germany","status":"Anlage I","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"United Nations","status":"Schedule I psychotropic","act":"Convention on Psychotropic Substances 1971","refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/%CE%B1-Ethyltryptamine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/8367"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q2394183"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01546"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1619758"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A134838"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=2235-90-7"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID1046764"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=%CE%B1%2DEthyltryptamine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/GR181O3R32"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 8367, α-Ethyltryptamine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/8367>https://pubchem.ncbi.nlm.nih.gov/compound/8367</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. α-Ethyltryptamine. UNII: GR181O3R32. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GR181O3R32>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GR181O3R32</a>","RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 14:59:59","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 14:59:55","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 14:59:55","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 14:59:57","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 14:59:55","note":"no HMDB id"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 14:59:59","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 14:59:53","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 14:59:55","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 14:59:55","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 14:59:55","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 14:59:55","note":null}],"description":"α-Ethyltryptamine is a entactogen, stimulant substance."}